VolitionRx VolitionRx Awarded Additional $4 Million in Funding The company said that part of the funding was an unsecured loan to support the analysis of tumor DNA using a nucleosome immunoprecipitation method. VolitionRx, 4D Lifetec Partner to Combine Early Cancer Detection Assays The companies said Tuesday that they are pursuing a clinical trial utilizing their respective liquid biopsy assays on clinical samples from lung cancer patients. VolitionRx Receives $700K in Funding From Regional Government A portion of the funding, which is from the government of the Wallonia region of Belgium, is repayable over 12 years. VolitionRx, Active Motif Sign Global Sales, Distribution Agreement VolitonRx's research-use-only kits can be used to examine patterns in circulating nucleosomes in disease models, preclinical testing, and clinical trials. VolitionRx Gets CE Mark for Colorectal Cancer Screening Test The test combines two previously CE marked assays that are based on the company's Nucleosomics platform for identifying and quantifying nucleosome structural features. Jun 3, 2016 VolitionRx Readying Launch of First Cancer Test Panel Using Circulating Nucelosome Technology Premium May 12, 2016 VolitionRx Launches Clinical Trial in Germany for Pancreatic Cancer Blood Test Apr 7, 2016 VolitionRx Receives CE Marking for Two Colorectal Cancer Dx Assays Sep 22, 2015 VolitionRx Receives CE Mark for Colorectal Cancer Diagnosis Assay Mar 5, 2015 VolitionRx, ImmuneHealth Collaborate on Prostate Cancer Study Feb 24, 2015 VolitionRx Acquires Nucleosome Analysis IP from Chroma Therapeutics Feb 12, 2015 VolitionRx Closes Public Offering, Raises $8.5M Feb 6, 2015 VolitionRx Begins Trading on NYSE MKT, Prices Public Offering at $3.75 per Share Breaking News Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.